THRAP3 and metabolic dysfunction-associated steatotic liver disease: Taken together, these results demonstrate that liver-specific deletion of Thrap3 confers systemic protection against diet-induced obesity and NAFLD without affecting the expression of FA β-oxidation- and lipogenesis-associated genes.